Je was op zoek naar: sulfonylmočovinou (Slovaaks - Engels)

metformínom a sulfonylmočovinou
metformin and a sulphonylurea

hypoglykémia (so sulfonylmočovinou)
hypoglycaemia (with a sulphonylurea)

rosiglitazón s metformínom a sulfonylmočovinou
rosiglitazone with metformin and sulphonylurea

metformín (základná liečba sulfonylmočovinou)
metformin (background sulphonylurea)

výnimku tvorí kombinácia so sulfonylmočovinou.
there is no need to change the doses of the other medicines januvia is taken with, except when januvia is taken with a sulphonylurea.

pioglitazÓn v kombinÁcii s lieČbou sulfonylmoČovinou
pioglitazone in combination therapy with sulphonylurea

hypoglykémia (s metformínom a sulfonylmočovinou) 2
hypoglycaemia (with metformin and a sulphonylurea)2

prídavná liečba k liečbe metformínom a sulfonylmočovinou
add-on to metformin and a sulphonylurea therapy

sulfonylmočovinou a jednou zo zložiek lieku qtern,
a sulphonylurea and one of the components of qtern;

saxagliptín pridaný v kombinovanej liečbe s metformínom a sulfonylmočovinou
saxagliptin add-on combination therapy with metformin and sulphonylurea

hypoglykémia (pri užívaní so sulfonylmočovinou alebo inzulínom)1
hypoglycaemia (when used

pioglitazÓn v kombinÁcii s lieČbou sulfonylmoČovinou ochorenia ucha a labyrintu
pioglitazone in combination therapy with sulphonylurea ear and labyrinth disorders

linagliptín ako prídavná liečba ku kombinovanej liečbe metformínom a sulfonylmočovinou
linagliptin as add-on to a combination of metformin and sulphonylurea therapy

pri kombinovanej liečbe so sulfonylmočovinou alebo inzulínom môže dôjsť k hypoglykémii.
hypoglycaemia may occur in combination with sulphonylureas or insulin.

- v trojitej perorálnej terapii so sulfonylmočovinou u pacientov s nedostatočnou kompenzáciou
- in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite

nezdá sa, že by súčasné podanie pioglitazónu so sulfonylmočovinou ovplyvnilo jej farmakokinetiku.
co-administration of pioglitazone with sulphonylureas does not appear to affect the pharmacokinetics of the sulphonylurea.

- so sulfonylmočovinou, len u pacientov, ktorí metformín netolerujú alebo je u nich
as dual oral therapy in combination with – metformin, in patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin – a sulphonylurea, only in patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite monotherapy with a sulphonylurea

avandamet sa môže používať samostatne alebo spolu so sulfonylmočovinou, ďalším liekom na diabetes.
avandamet can be used alone or with a sulphonylurea, another medicine for diabetes.

približne tretina pacientov dostávala inzulín v kombinácii s metformínom a/alebo sulfonylmočovinou.
approximately one third of patients were receiving insulin in combination with metformin and/or a sulphonylurea.

na štúdiách sa zúčastnilo 1 390 pacientov, ktorým bol k existujúcej liečbe sulfonylmočovinou pridaný pioglitazón.
the studies included 1,390 patients who added pioglitazone to their existing treatment with a sulphonylurea.